Peptide LibraryHuman study PLS-00246
BPC 157 for Acute Hamstring Muscle Strain Repair
Version 1 · published November 8, 2026 · evidence through November 8, 2026 · research snapshot 2026.1.1 · methodology ev-1 · Automated assessment by AI (claude-opus-5-5 and claude-sonnet-5-5), not reviewed by a person.
Reports of this study
Every publication, registration and abstract describing this one study. Participants are counted once.
- BPC 157 for Acute Hamstring Muscle Strain Repairregistry entry · NCT07437547 (RECRUITING, no results posted, planned enrollment 120)
Design and participants
- Design
- Other design
- Population
- People with acute hamstring muscle strain (skeletal muscle injury); eligibility details not given in the record
- Conditions
- Hamstring Muscle Strain, Skeletal Muscle Injury
- Planned enrollment (registry)
- 120
- Enrolled
- Not reported
- Randomized
- Not reported
- Completed follow-up
- Not reported
Intervention and comparator
What each group received. Related peptides, analogs and combinations are never treated as the compound itself.
- BPC 157 (intervention) · bpc-157 · Pentadecapeptide BPC 157 · Not reported assigned
- Placebo (comparator) · Placebo · placebo · Not reported assigned
What the authors reported
As stated in the sources. This is the authors’ account, not Peptide Library’s assessment.
Adverse events
None reported. That is not evidence of safety, and how safety was monitored isn’t described.
Peptide Library’s assessment
An automated assessment, made by AI separately from the authors’ conclusions and not reviewed by a person. How risk of bias is assessed.
Limitations
- other: The record lists a placebo arm but does not state whether allocation was randomized or blinded.
- selective reporting: No registered outcome measures are given in the record, so planned endpoints cannot be checked against later reporting.
- small or imprecise: Planned enrollment is an estimate of 120 and no actual enrollment is reported.
No risk-of-bias assessment has been published for this study’s results.
Claims this study informs
- Reduces knee pain: not eligible (wrong population) for “Knee pain intensity”
- Supports tendon injury recovery: not eligible (wrong population) for “Function and return to activity”
- Improves muscle injury recovery: not eligible (insufficient data) for “Time to return to activity”
- Improves gastrointestinal conditions: not eligible (wrong population) for “Clinical response or remission”
- Is safe for human administration: not eligible (insufficient data) for “Adverse events, serious adverse events and discontinuations”
Where each value comes from
- arms: NCT NCT07437547, registry (interventions) · extracted by AI (automated, not verified by a person)
- design: NCT NCT07437547, registry (study_type, phases) · extracted by AI (automated, not verified by a person)
- limitations: NCT NCT07437547, registry (status, has_results) · extracted by AI (automated, not verified by a person)
- participants: NCT NCT07437547, registry (enrollment, enrollment_type) · extracted by AI (automated, not verified by a person)
- population: NCT NCT07437547, registry (conditions) · extracted by AI (automated, not verified by a person)
Version 1 · published November 8, 2026 · evidence through November 8, 2026 · research snapshot 2026.1.1 · methodology ev-1 · Automated assessment by AI (claude-opus-5-5 and claude-sonnet-5-5), not reviewed by a person.
These assessments describe published research. Records marked automated were produced by AI under the published methodology and have not been reviewed by a person; they can contain errors. None of this is medical advice, not a statement about any product’s safety for human use, and not a regulatory approval. Peptide Library’s vendor and partner relationships play no part in them (editorial independence).